You may be able to pay less for prescription drugs by skipping insurance and paying cash. Using discounts available from ...

Insurance coverage for GLP-1 drugs remains tight despite rising demand, with more patients facing restrictions or paying out ...

Healthcare tech company GoodRx (NASDAQ:GDRX) will be announcing earnings results tomorrow before the bell. Here’s what investors should know. GoodRx met analysts’ revenue expectations last ...

Eli Lilly is offering vials of its obesity drug Zepbound to patients at a discount — but only if they skip their insurance.

Health-care professionals, eager to support their patients diagnosed with diabetes or obesity, are writing more prescriptions ...

The value proposition is clear. GoodRx makes it easy for people to save time and money when filling medications, complementing insurance by filling in the inevitable and growing coverage gaps and ...

Commercial insurance coverage of blockbuster GLP-1 drugs has not expanded much over the past year, despite growing demand and expanded indications, according to a new report from GoodRx. Data from ...

GoodRx Holdings Inc (NASDAQ:GDRX) is set to release its Q4 2024 earnings on Feb 27, 2025. The consensus estimate for Q4 2024 revenue is $199.75 million, and the earnings are expected to come in at ...

In this article, we are going to take a look at where GoodRx Holdings, Inc. (NASDAQ:GDRX) stands against the other cash-rich small cap stocks. Small-cap stocks in the US have been under pressure ...